Search research articles
Contact Us
Filters
Showing results (11-20 of 166) with videos related to
Page
of 17
Sort By:
Tropical Medicine and Infectious Disease
|
February 24, 2023
Concomitant Severe Psoriasis and Bullous Pemphigoid Induced by COVID-19
Fabrizio Martora, Teresa Battista, Gabriella Fabbrocini, et al.
Clinical and Experimental Dermatology
|
January 20, 2023
Comment on 'Eosinophilic pustular folliculitis developing at the site of COVID-19 vaccination'
Fabrizio Martora, Teresa Battista, Gabriella Fabbrocini, et al.
Skin Appendage Disorders
|
June 16, 2022
A Case of Pemphigus Vulgaris and Hidradenitis Suppurativa: May Systemic Steroids Be Considered in the Standard Management of Hidradenitis Suppurativa?
Fabrizio Martora, Lorenzo Martora, Gabriella Fabbrocini, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 9, 2024
Reply to "Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa"
Fabrizio Martora, Luca Potestio, Teresa Battista, et al.
Dermatologic Therapy
|
August 26, 2022
Impact of COVID-19 pandemic and the use of telemedicine on the diagnosis and treatment of tinea corporis: An experience of Southern Italy center
Vincenzo Picone, Lucia Gallo, Gabriella Fabbrocini, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 20, 2024
Reply to 'Effectiveness, safety and drug survival of oral roflumilast for hidradenitis suppurativa' by Holgersen et al
Fabrizio Martora, Teresa Battista, Luca Potestio, et al.
Clinical and Experimental Dermatology
|
June 3, 2022
Video and telephone teledermatology consultations during COVID-19 in comparison: patient satisfaction, doubts and concerns
Angelo Ruggiero, Matteo Megna, Gabriella Fabbrocini, et al.
Clinical and Experimental Dermatology
|
June 14, 2022
Strategies adopted in a southern Italian referral centre to reduce adalimumab discontinuation: comment on 'Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?'
Fabrizio Martora, Claudio Marasca, Gabriella Fabbrocini, et al.
Dermatology and Therapy
|
February 15, 2022
A Case of New-Onset Lichen Planus after COVID-19 Vaccination
Vincenzo Picone, Gabriella Fabbrocini, Lorenzo Martora, et al.
Dermatologic Therapy
|
November 9, 2021
"Covid arm": Abnormal side effect after Moderna COVID-19 vaccine
Vincenzo Picone, Fabrizio Martora, Gabriella Fabbrocini, et al.
Page
of 17
Search research articles
Search
Showing results (11-20 of 166) with videos related to
Sort By:
Page
of 17
Tropical Medicine and Infectious Disease
|
February 24, 2023
Concomitant Severe Psoriasis and Bullous Pemphigoid Induced by COVID-19
Fabrizio Martora, Teresa Battista, Gabriella Fabbrocini, et al.
Clinical and Experimental Dermatology
|
January 20, 2023
Comment on 'Eosinophilic pustular folliculitis developing at the site of COVID-19 vaccination'
Fabrizio Martora, Teresa Battista, Gabriella Fabbrocini, et al.
Skin Appendage Disorders
|
June 16, 2022
A Case of Pemphigus Vulgaris and Hidradenitis Suppurativa: May Systemic Steroids Be Considered in the Standard Management of Hidradenitis Suppurativa?
Fabrizio Martora, Lorenzo Martora, Gabriella Fabbrocini, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 9, 2024
Reply to "Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa"
Fabrizio Martora, Luca Potestio, Teresa Battista, et al.
Dermatologic Therapy
|
August 26, 2022
Impact of COVID-19 pandemic and the use of telemedicine on the diagnosis and treatment of tinea corporis: An experience of Southern Italy center
Vincenzo Picone, Lucia Gallo, Gabriella Fabbrocini, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 20, 2024
Reply to 'Effectiveness, safety and drug survival of oral roflumilast for hidradenitis suppurativa' by Holgersen et al
Fabrizio Martora, Teresa Battista, Luca Potestio, et al.
Clinical and Experimental Dermatology
|
June 3, 2022
Video and telephone teledermatology consultations during COVID-19 in comparison: patient satisfaction, doubts and concerns
Angelo Ruggiero, Matteo Megna, Gabriella Fabbrocini, et al.
Clinical and Experimental Dermatology
|
June 14, 2022
Strategies adopted in a southern Italian referral centre to reduce adalimumab discontinuation: comment on 'Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?'
Fabrizio Martora, Claudio Marasca, Gabriella Fabbrocini, et al.
Dermatology and Therapy
|
February 15, 2022
A Case of New-Onset Lichen Planus after COVID-19 Vaccination
Vincenzo Picone, Gabriella Fabbrocini, Lorenzo Martora, et al.
Dermatologic Therapy
|
November 9, 2021
"Covid arm": Abnormal side effect after Moderna COVID-19 vaccine
Vincenzo Picone, Fabrizio Martora, Gabriella Fabbrocini, et al.
Page
of 17